Skip to main content
main-content

06-12-2018 | Breast cancer | Video

Radiotherapy comparable to axillary lymph node dissection for locoregional control in breast cancer patients with a positive sentinel lymph node

Emiel Rutgers gives an overview of the 10-year follow-up results from the EORTC AMAROS trial demonstrating that radiotherapy has equivalent locoregional control to that of axillary lymph node dissection  but with a reduced risk of lymphedema (4:28).

Funding for these videos was provided by F. Hoffmann-La Roche Ltd, Basel, Switzerland

image credits